Ghana becomes first country to approve Oxford’s malaria vaccine

Ghana becomes first country to approve Oxford’s malaria vaccine

Recently Ghana has become the first country in the world to approve the malaria vaccine.

  • The Food and Drug Authority of Ghana has approved the use of this new vaccine called ‘R21’ in children aged five months to three years.
  • R21 – Appears to be extremely effective unlike previous attempts in the same area.
  • Ghana’s drug regulator has assessed final trial data on the safety and effectiveness of the vaccine, which has not yet been made public, and decided to use it.
  • The World Health Organization is also considering approving the vaccine.
  • The vaccine has been developed at Oxford University and the Serum Institute of India is preparing to produce between 100-200 million doses per year. For this a vaccine factory is being built in Accra, Ghana.
  • Let us tell you that earlier in October 2021, WHO also recommended the use of RTS, S vaccine for children living in areas with moderate and high transmission of malaria.

About Malaria

  • Malaria is an acute febrile disease caused by the Plasmodium parasite, which is transmitted to humans through the bite of infected female Anopheles mosquitoes.
  • It is preventable and treatable. Malaria is not contagious and cannot spread from person to person; The disease is spread by the bite of female Anopheles mosquitoes.
  • Five species of parasites can cause malaria in humans, and two of these species, Plasmodium falciparum and Plasmodium vivax, pose the greatest threat.
  • There are more than 400 different species of Anopheles mosquitoes and about 40, known as vector species, can transmit disease.
  • Artemisinin-based combination therapies (ACTs) are the most effective anti-malarial drugs available today.

Source – Business Standard

Download Our App

More Current Affairs

Share with Your Friends

Join Our Whatsapp Group For Daily, Weekly, Monthly Current Affairs Compilations

Related Articles

Youth Destination Facilities